Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (28)

1

Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients : Open-label randomized controlled trial (EFFaCo study)

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Siripongboonsitti, T. | Ungtrakul, T. | Tawinprai, K. | +6

2

Experimental Studies on Some Drugs Used in Covid-19 Treatment (Favipiravir and Dexamethasone) in Albino Rats

in: Journal of Advanced Veterinary Research | 2023

von Moustafa S. Abou El-Fetouh | Nora M. El-Seddawy | Manar A. Abdel Mageed | +1

3

Rapid and ecofriendly UPLC quantification of Remdesivir, Favipiravir and Dexamethasone for accurate therapeutic drug monitoring in Covid-19 Patient's plasma

enthalten in: Microchemical journal : devoted to the application of microtechniques in all branches of science | 2022

von Emam, A. | Abdelaleem, E. | Abdelmomen, E. | +2

4

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

5

Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia

enthalten in: Journal of infection and public health | 2022

von Mutair, A. | Shamou, J. | Alhumaid, S. | +11

6

Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia

in: Journal of Infection and Public Health | 2022

von Abbas Al Mutair | Jinan Shamou | Saad Alhumaid | +11

7

COVID-19 : molecular pathophysiology, genetic evolution and prospective therapeutics-a review

enthalten in: Archives of microbiology | 2021

von Raj, C. | Kandaswamy, D. | Danduga, R. | +2

8

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment

enthalten in: SN comprehensive clinical medicine | 2021

von Kelleni, M.

9

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment

enthalten in: SN comprehensive clinical medicine | 2021

von Kelleni, M.

10

Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone

enthalten in: Current pharmacology reports | 2021

von Sood, S. | Bhatia, G. | Seth, P. | +5